HEALTH● LOW2h ago · Oct 24, 2026, 5:38 AM
U.S. FDA issues four observations to Gland Pharma formulation facility near Hyderabad
The Hindu · south asia
The four Form 483 observations followed an unannounced inspection on current good manufacturing practice at the facility in Dundigal between October 12 and 23
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH42m agoWinter time or summer time? What the science says about the best option for healthEuroNews [en]HEALTH1h agoEbola vaccine trial begins in DR CongoVanguard NigeriaHEALTH1h agoClocks turn back on November 1: how to maintain your biological clock and sleep well with the time changeClarínHEALTH1h agoPsychology says that parents who have good intentions but still deeply hurt their children often say 6 phrases in informal conversationsClarín